Stock Quote

COV (Common Stock)
ExchangeNYSE
(US Dollar)
Price$44.05
Change (%) Stock is Down 0.13
 (0.29%)
Volume1,471,815
As of 11/06/09 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Tool Kit

Printer Friendly Version    Printer-friendly version
E-mail this page   E-mail this page
RSS    RSS Feeds
E-mail Alerts Receive E-mail Alerts
View contacts     View contacts

Investor Relations Home

Webcast ImageWebcast
Q4 2009 Covidien Plc. Earnings Conference Call (Live)
11/17/09 at 8:30 a.m. ET
Q4 2009 Covidien Plc. Earnings Conference Call
Tuesday, November 17, 2009 8:30 a.m. ET  
Webcast PresentationHelp Help
Listen to the Webcast in Windows Media Player Click here for webcast
Recent NewsMore >>
Covidien Completes Acquisition of Aspect Medical Systems Inc. - 11/06/09
DUBLIN--(BUSINESS WIRE)--Nov. 6, 2009-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of Aspect Medical Systems Inc. for an ... More >>
Covidien Successfully Completes Tender Offer for Shares of Aspect Medical Systems, Inc. - 11/06/09
DUBLIN--(BUSINESS WIRE)--Nov. 6, 2009-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, Transformer Delaware Corp.,... More >>
FDA Approves Pennsaid(R) Topical Solution - 11/05/09
Covidien, Nuvo Research Inc. Collaboration Achieves Significant Milestone in Support of Covidien’s Expansion in Branded Pain Management Market ST. LOUIS & MISSISSAUGA, Ontario--(BUSINESS WIRE)--Nov. 5, 200... More >>
Covidien to Present at Credit Suisse Healthcare Conference - 11/04/09
MANSFIELD, Mass.--(BUSINESS WIRE)--Nov. 4, 2009-- Covidien (NYSE: COV) will present at the Credit Suisse 18th Annual Healthcare Conference in Phoenix on Wednesday, November 11, 2009. Charles J. Dockendorff, Executive Vice Pre... More >>
Covidien Receives FDA Approval for Oral Transmucosal Fentanyl Citrate Product - 10/30/09
ST. LOUIS, Oct 30, 2009 (BUSINESS WIRE) -- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval o... More >>
Covidien Announces Global Launch of Mallinckrodt(TM) TaperGuard(TM) Line of Endotracheal Tubes - 10/19/09
New taper-shaped cuff reduces risk of microaspiration BOULDER, Colo.--(BUSINESS WIRE)--Oct. 19, 2009-- Covidien (NYSE: COV), a leading global healthcare products company and recognized innovator in mechanical ventil... More >>
Covidien Teams with Women's Pro Basketball Legend Lisa Leslie on Liver Cancer Education Program - 10/15/09
BOULDER, Colo.--(BUSINESS WIRE)--Oct. 15, 2009-- Four-time Olympic gold medal winner and three-time WNBA Most Valuable Player Lisa Leslie is teaming with Covidien (NYSE: COV), a leading global provider of healthcare products,... More >>
Covidien Introduces Revolutionary Wound Closure Device - 10/12/09
New V-Loc™ device enables knotless soft tissue repair, offering the most significant advance since absorbable sutures NORTH HAVEN, Conn.--(BUSINESS WIRE)--Oct. 12, 2009-- Covidien (NYSE: COV), a leading global... More >>
Covidien plc to Report Fourth-Quarter Results on November 17, 2009 - 10/06/09
DUBLIN--(BUSINESS WIRE)--Oct. 6, 2009-- Covidien plc (NYSE: COV) will report fourth-quarter results before trading begins on November 17, 2009. The Company will hold a conference call for investors at 8:30 a.m. ET. The call c... More >>
Covidien Receives FDA Clearance for its Mallinckrodt(TM) TaperGuard(TM) Evac Endotracheal Tube - 09/30/09
BOULDER, Colo., Sep 30, 2009 (BUSINESS WIRE) -- Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today announced that it has receiv... More >>
Upcoming EventsMore >>
DateTitle
11/11/09 5:00 p.m. ET
Covidien Plc. at Credit Suisse Healthcare Conference
LocationPhoenix, AZ
11/17/09 8:30 a.m. ET
Q4 2009 Covidien Plc. Earnings Conference Call
November 2009?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
1234567
891011121314
15161718192021
22232425262728
29305152535455
Featured Report
Download Documentation 2008 Annual Report
What's New